Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1993-11-29
|
pubmed:abstractText |
The effect of morphine treatment on immunocompetence was investigated in rhesus monkeys (Mucaca mulatta). Monkeys that received morphine daily (3.2 mg/kg) had suppressed peripheral blood mononuclear cell (PBMC) natural killer (NK) activity as well as a decrease in the percentage of CD8+CD16+ cells compared with saline-treated (controls) or infrequently treated (i.e., opioids once or twice weekly) monkeys. However, an increase (20 +/- 5%) in the percentage of CD8+ lymphocytes was found in both the daily and infrequent opioid-treated monkeys compared with controls. Conversely, the percentage of total CD4+ lymphocytes and CD4+CD45RA+ was reduced (12 +/- 2% and 28 +/- 10% respectively) in both daily and infrequent opioid-treated animals compared with saline-treated controls. In a reciprocal fashion, there was an increase in the CD4+CD29+ population in daily morphine-treated monkeys (54% of the total CD4+ cells) compared with untreated animals (37% of the total CD4+ cells). In addition, cultured PBMC obtained from monkeys treated daily with morphine produced significantly (P < .01) more polyclonal immunoglobulin (Ig) G (366 ng/ml) and polyclonal IgM (233 ng/ml) compared with PBMC production of polyclonal IgG (96 ng/ml) and polyclonal IgM (67 ng/ml) from saline-treated controls. However, no differences were found in the percentage of CD19+ lymphocytes among any of the groups. In summary, daily treatment with a relatively low dose of morphine (3.2 mg/kg) affects immunocompetence which could have important implications in the regulation of viral pathogens in i.v. drug abusers (e.g., AIDS).
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD29,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD45,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Morphine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-3565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
267
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
9-15
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7693915-Animals,
pubmed-meshheading:7693915-Antibody Formation,
pubmed-meshheading:7693915-Antigens, CD,
pubmed-meshheading:7693915-Antigens, CD29,
pubmed-meshheading:7693915-Antigens, CD45,
pubmed-meshheading:7693915-CD4-Positive T-Lymphocytes,
pubmed-meshheading:7693915-Female,
pubmed-meshheading:7693915-Immunity, Cellular,
pubmed-meshheading:7693915-Immunologic Memory,
pubmed-meshheading:7693915-Interleukin-2,
pubmed-meshheading:7693915-Killer Cells, Natural,
pubmed-meshheading:7693915-Macaca mulatta,
pubmed-meshheading:7693915-Male,
pubmed-meshheading:7693915-Morphine,
pubmed-meshheading:7693915-T-Lymphocyte Subsets
|
pubmed:year |
1993
|
pubmed:articleTitle |
Immune alterations in morphine-treated rhesus monkeys.
|
pubmed:affiliation |
Department of Microbiology, Immunology and Parasitology, Louisiana State University Medical Center, New Orleans.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|